Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.
about
Pharmacogenomics of breast cancer therapy: an updateReporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.Prolylcarboxypeptidase regulates proliferation, autophagy, and resistance to 4-hydroxytamoxifen-induced cytotoxicity in estrogen receptor-positive breast cancer cells.Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer.Association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with Bacillus Calmette-Guérin.Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer.Oxidative stress-related genetic polymorphisms are associated with the prognosis of metastatic gastric cancer patients treated with epirubicin, oxaliplatin and 5-fluorouracil combination chemotherapy.Doxorubicin pathways: pharmacodynamics and adverse effects.Breast cancer therapy and cardiovascular risk: focus on trastuzumabActionable pharmacogenetic markers for prediction and prognosis in breast cancer.Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational researchIdentification of candidate polymorphisms on stress oxidative and DNA damage repair genes related with clinical outcome in breast cancer patients.Critical roles for nitric oxide and ERK in the completion of prosurvival autophagy in 4OHTAM-treated estrogen receptor-positive breast cancer cells.Pharmacogenetics of genes across the doxorubicin pathway.Pharmacogenomics and the treatment of acute myeloid leukemia.Association of superoxide dismutases and NAD(P)H quinone oxidoreductases with prognosis of patients with breast carcinomas.Association of nitric oxide synthase 3 (NOS3) 894 G>T polymorphism with prognostic outcomes of anthracycline in Chinese patients with acute myeloid leukaemia.Genetic Variants Associated with Clinicopathological Profiles in Sporadic Breast Cancer in Sri Lankan Women.
P2860
Q27006783-C805D57A-A8F8-44E3-A809-F421227B2768Q30514241-FED6F685-952F-4DB4-9214-074B0C373E21Q33750907-314FB29E-EEA3-4483-9995-5E824827E903Q34262314-D1DD1ACE-57D6-4836-8831-395E7CC2E6EEQ34305503-2C901AC6-B112-4F7E-99A0-127A1A39206AQ34682560-2A26131E-AB79-4978-82F3-AB9942C45EA6Q34783589-176B2BAC-979A-46E9-BD63-9E4667248E04Q35048393-E64E719D-6B4D-4DD2-A361-C57D05C3B64BQ35427876-08A5B4CD-498D-4D85-880C-74B4BECB2EFEQ35879741-2CC714FA-11D7-411F-ABFF-017193CC1325Q36535678-17AF8F04-4C89-419D-8CCF-6E58CFDAD52BQ36538460-CC7F14FF-1870-4CD1-9C8F-368542A5E2C8Q36787062-A5942927-7013-447B-A5C4-00B93CDA79CAQ37932556-FAA1FECA-64B1-4A51-A323-7C63A7AB387CQ38887034-15189F08-1D89-4A07-A0A7-DA2603B63099Q44221204-D304D204-FFFC-44E5-B538-E40EC943BC49Q54363661-DC69926B-8AC6-4622-B0A5-E0E8E3BE58CDQ55500887-8F2DD29F-A2A7-455C-9617-4F55EAEC5580
P2860
Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nitric oxide synthase variants ...... Oncology Group clinical trial.
@en
Nitric oxide synthase variants ...... Oncology Group clinical trial.
@nl
type
label
Nitric oxide synthase variants ...... Oncology Group clinical trial.
@en
Nitric oxide synthase variants ...... Oncology Group clinical trial.
@nl
prefLabel
Nitric oxide synthase variants ...... Oncology Group clinical trial.
@en
Nitric oxide synthase variants ...... Oncology Group clinical trial.
@nl
P2093
P2860
P1476
Nitric oxide synthase variants ...... Oncology Group clinical trial.
@en
P2093
Alan P Lyss
C Kent Osborne
Chi-Chen Hong
Daniel F Hayes
I-Tien Yeh
James M Rae
Javier G Blanco
Ji-Yeob Choi
Kathy S Albain
Laura F Hutchins
P2860
P304
P356
10.1158/1078-0432.CCR-09-0685
P407
P577
2009-08-11T00:00:00Z